Eam Investors, LLC Ovid Therapeutics Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$2.28 - $6.84 $276,144 - $828,433	-121,116 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$5.39 - $8.24 $342,868 - $524,162	-63,612 Reduced 34.44%	121,116 $695,000
Q1 2020 May 13, 2020	SELL	$2.03 - $4.35 $203,684 - $436,465	-100,337 Reduced 35.2%	184,728 $550,000
Q4 2019 Feb 11, 2020	BUY	$2.08 - $5.06 $164,209 - $399,471	78,947 Added 38.3%	285,065 $1.18 Million
Q3 2019 Nov 13, 2019	BUY	$1.76 - $3.51 $362,767 - $723,474	206,118 New	206,118 $668,000

41.2M

2.4K

200

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $20.4M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.